Arkansas Center for Food Allergy Research (ArCOFAR)

阿肯色州食物过敏研究中心 (ArCOFAR)

基本信息

  • 批准号:
    10581677
  • 负责人:
  • 金额:
    $ 23.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-03-03 至 2024-02-29
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Food allergy is a disease of global impact associated with life-threatening reactions, increasing prevalence, and limited options for treatment and prevention. Despite significant research advances, many remaining questions must be addressed before global implementation of impactful therapeutic and prevention options for patients affected by food allergy can be realized. The Consortium for Food Allergy Research (CoFAR) was formed to address these unresolved questions through its collaborative research network of Clinical Research Units (CRU) with experience and expertise in food allergy clinical trials. To this end, the Arkansas Center for Food Allergy Research (ArCOFAR) builds on a >30 year foundation of excellence, expertise, and leadership in food allergy and is prepared to immediately address the overarching program goals of CoFAR. The ArCOFAR site is ideally-positioned to function as a CoFAR CRU through contribution of our extensive research experience and by capitalizing on our population's unique geographic and patient demographic characteristics. Our efforts will be directed by the central hypothesis that ArCOFAR will enable the participation of diverse groups of food allergic individuals in expertly designed, innovative clinical trials of the highest quality and scientific value. Our overarching goal is to provide a unique research platform to measurably improve the lives of children and adults with food allergy. This goal will be accomplished by the design and implementation of innovative clinical studies and therapeutic trials via high-quality, high-impact research collaboration. Our hypothesis will be tested by executing four specific aims: 1) Leverage established expertise in food allergy research as a platform to expand clinical trials development in immunotherapeutics through integrated research efforts with other CoFAR CRUs; 2) Apply institutional and community resources to expand ArCOFAR CRU capacity for population-based research in food allergy, including participation in birth cohort and longitudinal outcome studies; 3) Link current inter- and intra-institutional resources to broaden the scope of clinical research participation to include a more diverse population of food allergic patients; 4) Promote career development of new and early career food allergy researchers through active recruiting and mentoring of new faculty and linking established programmatic and network resources. In addition, our cutting-edge clinical trial of walnut oral immunotherapy will address an unmet need in management of tree nut allergy. Further, ArCOFAR's multi-disciplinary team with established expertise and international leadership in food allergy clinical trials, will expand clinical research through the development and testing of novel immunotherapeutics and implementation of cohort studies, while providing mentoring and career development opportunities to early and new career investigators. The outcome of this proposal will be to improve the health of children and adults with food allergy in Arkansas and beyond while advancing the mission of CoFAR to fundamentally change the field of food allergy.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stacie M Jones其他文献

Enhanced β2-adrenergic receptor (β2AR) signaling by adeno-associated viral (AAV)-mediated gene transfer
  • DOI:
    10.1186/1471-2210-3-15
  • 发表时间:
    2003-12-04
  • 期刊:
  • 影响因子:
    2.700
  • 作者:
    Stacie M Jones;F Charles Hiller;Sandie E Jacobi;Susan K Foreman;Laura M Pittman;Lawrence E Cornett
  • 通讯作者:
    Lawrence E Cornett

Stacie M Jones的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stacie M Jones', 18)}}的其他基金

Arkansas Center for Food Allergy Research (ArCOFAR)
阿肯色州食物过敏研究中心 (ArCOFAR)
  • 批准号:
    10339376
  • 财政年份:
    2017
  • 资助金额:
    $ 23.5万
  • 项目类别:
ROLE OF FOOD HYPERSENSITIVITY IN ATOPIC DERMATITIS
食物过敏在特应性皮炎中的作用
  • 批准号:
    7203370
  • 财政年份:
    2005
  • 资助金额:
    $ 23.5万
  • 项目类别:
THE NATURAL HISTORY OF PEANUT AND NUT PROTEIN ALLERGY
花生和坚果蛋白过敏的自然史
  • 批准号:
    7203412
  • 财政年份:
    2005
  • 资助金额:
    $ 23.5万
  • 项目类别:
Role of food hypersensitivity in atopic dermatitis
食物过敏在特应性皮炎中的作用
  • 批准号:
    6975585
  • 财政年份:
    2004
  • 资助金额:
    $ 23.5万
  • 项目类别:
The Natural History of Peanut and Nut Protein Allergy
花生和坚果蛋白过敏的自然史
  • 批准号:
    6975621
  • 财政年份:
    2004
  • 资助金额:
    $ 23.5万
  • 项目类别:
BETA2-ADRENERGIC RECEPTOR DOWN-REGULATION IN ASTHMA
哮喘中的β2-肾上腺素受体下调
  • 批准号:
    6761907
  • 财政年份:
    2000
  • 资助金额:
    $ 23.5万
  • 项目类别:
BETA2-ADRENERGIC RECEPTOR DOWN-REGULATION IN ASTHMA
哮喘中的β2-肾上腺素受体下调
  • 批准号:
    6532638
  • 财政年份:
    2000
  • 资助金额:
    $ 23.5万
  • 项目类别:
BETA2-ADRENERGIC RECEPTOR DOWN-REGULATION IN ASTHMA
哮喘中的β2-肾上腺素受体下调
  • 批准号:
    6653031
  • 财政年份:
    2000
  • 资助金额:
    $ 23.5万
  • 项目类别:
BETA2-ADRENERGIC RECEPTOR DOWN-REGULATION IN ASTHMA
哮喘中的β2-肾上腺素受体下调
  • 批准号:
    6190615
  • 财政年份:
    2000
  • 资助金额:
    $ 23.5万
  • 项目类别:
BETA2-ADRENERGIC RECEPTOR DOWN-REGULATION IN ASTHMA
哮喘中的β2-肾上腺素受体下调
  • 批准号:
    6372714
  • 财政年份:
    2000
  • 资助金额:
    $ 23.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 23.5万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.5万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 23.5万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 23.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 23.5万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 23.5万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 23.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了